N,N-Dimethyltryptamin

Overview

DMT (N,N-Dimethyltryptamine) is a naturally occurring tryptamine alkaloid found in many plants and animals. It acts primarily as a potent 5-HT2A receptor agonist, producing intense, short-lived psychedelic experiences with profound alterations in perception, cognition, and self-sense.

Effects

Subjective

• DMT induces an almost immediate immersion into vivid, geometric, and often inhabited inner worlds.
• Ego boundaries dissolve, time disappears, and the emotional tone ranges from blissful unity to existential terror.
• The experience is often described as a sudden “breakthrough” into another realm.

Physical

• Rapid onset with elevated heart rate, pupil dilation, tremors, and steady breathing.
• In Ayahuasca, the onset is slower, often accompanied by purging before settling into deep, reflective visions.

Combinations

• With harmalas, DMT becomes orally active and prolonged, producing the visionary brew Ayahuasca. The onset is slower, often accompanied by “purging” before settling into deep, reflective visions.

---

Story

Western (Re)discovery of DMT: The Szára Era

• Early traces — DMT (N,N-Dimethyltryptamine) was first identified in the 1940s in hallucinogenic snuffs such as paricá, yopo, and cébil, prepared from Anadenanthera seeds used by South American tribes.
• Scientific awareness — Chemically, DMT was first synthesized in 1931 by Richard Manske in Canada, though its psychoactivity wasn’t known. Reports from ethnobotanists in the 1940s–50s (e.g. Holmstedt, Schultes) suggested a link between these snuffs and powerful visions.
• Szára’s interest — In the 1950s, Hungarian chemist and psychiatrist Stephen Szára, working in Budapest, requested LSD from Sandoz for psychiatric research. The request was denied—partly due to Cold War restrictions on sending controlled substances behind the Iron Curtain.
• Do-it-yourself solution — Reading about structurally similar tryptamines (notably DMT in the literature of Manske and later Sporck), Szára synthesized DMT himself from tryptamine and dimethyl sulfate.
• Self-experimentation — He first tried it orally, found it inactive, then tried intramuscular injection—leading to intense, short-lived hallucinations.
• Early trials — Szára conducted controlled studies on about 30 medical colleagues and psychiatric patients, documenting vivid perceptual changes and the rapid onset/offset (about 10–15 minutes).
• Migration & U.S. research — After emigrating to the United States following the Hungarian Revolution (1956), Szára continued to study DMT at the NIH. However, LSD dominated psychedelic research, and DMT remained obscure outside small scientific circles.
• Reputation & nicknames — In underground circles, its brevity earned it the label “the businessman’s trip”, but many early subjects described it as overwhelmingly intense—sometimes terrifying—so it was also viewed as a “horror drug.”
• Endogenous discovery — In the 1960s, DMT was detected in the tissues of mammals and later in human blood, urine, and cerebrospinal fluid. This led to its classification as an endogenous psychotomimetic—a compound hypothesized to mimic or even cause psychosis when dysregulated.

1960s–1970s: Endogenous Psychosis Era

• Transmethylation hypothesis — Building on the discovery that DMT occurs in mammals, psychiatrists proposed that schizophrenia might arise from endogenous overproduction of hallucinogenic tryptamines, reframing psychosis as a biochemical imbalance rather than purely psychological disease. (DMT as “schizotoxin”)
• Searches and assays — Laboratories in the U.S., U.K., and Japan systematically assayed blood, urine, and CSF from patients and controls, but with inconsistent results. The enzyme capable of methylating tryptamine to DMT (indolethylamine N-methyltransferase (INMT)) was found
• Experimental studies confirmed DMT’s rapid onset and short duration, producing brief psychedelic experiences but failing to replicate the chronic, fragmented nature of schizophrenia. This gradually weakened the view of DMT as model.
• Cultural and political climate — As the 1960s ended, psychedelic research collapsed under growing legal restrictions. The 1970 Controlled Substances Act placed DMT in Schedule I, halting most clinical and biochemical studies.
• 1976 review and aftermath — The NIH paper The Psychedelic Model of Schizophrenia (1976) formally closed the theory, declaring it unproven and no longer worth pursuing. Its tone reflected the political pressure of the era more than scientific finality, effectively burying DMT research until its later revival.

1980s–1990s: Dormancy and Rediscovery

• Scientific silence — After the 1970s crackdown, almost no sanctioned research on DMT took place. The compound survived mainly as a footnote in psychopharmacology, occasionally mentioned in reviews on endogenous amines but largely forgotten in laboratories.
• Underground continuity — Outside academia, small circles of chemists and psychonauts—often inspired by Terence McKenna, Alexander Shulgin, and the remnants of the 1960s counterculture—began exploring DMT through vaporization rather than injection, discovering its distinct intensity and brevity.
• Mythic framing — These experiences gave rise to the now-famous descriptions of “breakthroughs,” “machine elves,” and “entities,” transforming DMT from a potential psychosis model into a metaphysical mystery. McKenna popularized it as “the most powerful hallucinogen on Earth.”
• Ethnobotanical bridge — At the same time, anthropologists and travelers studying ayahuasca in the Amazon highlighted that DMT had long been used in ritual form when combined with MAO-inhibiting plants. This cultural recontextualization reframed DMT as sacrament rather than toxin.
• Early revival — By the late 1980s, the combination of underground chemistry, anthropological insight, and shifting countercultural attitudes quietly reopened scientific curiosity.

1990s–2000s: The Spirit Molecule Era

• Clinical return — After two decades of silence, Rick Strassman at the University of New Mexico became the first researcher since Szára to receive U.S. approval to study DMT in human volunteers. Between 1990 and 1995, his team conducted over 400 controlled sessions with intravenous DMT.
• Experimental focus — Strassman’s studies measured blood levels, physiological responses, and psychological effects, documenting the compound’s rapid onset, short duration, and reproducible intensity. Many participants described encounters with entities, alternate realms, or “other intelligences.”
• Conceptual shift — Rather than treating DMT as a psychotomimetic, Strassman framed it as a gateway to extraordinary states of consciousness, speculating about roles in dreaming, near-death experiences, and birth/death processes.
• Publication and impact — His 2001 book, DMT - The Spirit Molecule, brought DMT back into public awareness, blending scientific observation with spiritual and existential questions. The later documentary (2010) amplified this cultural revival.
• Scientific response — While controversial, Strassman’s work reopened academic discussion about endogenous psychedelics and inspired new research into 5-HT2A receptor function, pineal biochemistry, and altered-state phenomenology.
• Cultural aftermath — DMT shifted from obscurity to symbol—seen as a bridge between neuroscience and mysticism, a compound sitting at the frontier of what science could measure and what consciousness could imagine.

2010s–2020s: The Contemporary Era

• Scientific resurgence — Building on Strassman’s work, researchers began revisiting endogenous DMT with modern analytical tools, leading to detection of measurable amounts in mammalian brains, renewing interest in its physiological and evolutionary role.
• Mechanistic insights — Work by Jimo Borjigin’s group (2013–2019) demonstrated DMT production in the pineal gland and multiple cortical regions of rodents, suggesting a wider neurochemical function than mythic speculation once implied.
• Neuroimaging and network studies — Experiments by Carhart-Harris, Timmermann, and collaborators showed that DMT disrupts the brain’s default mode network, increases global signal diversity, and evokes states comparable to dreaming or near-death experiences.
• Therapeutic curiosity — DMT entered early clinical exploration for depression, addiction, and end-of-life distress, mainly through short-acting formulations and through academic studies on ayahuasca analogues.
• Cultural normalization — Beyond science, DMT became deeply woven into global psychedelic culture. Ayahuasca Tourism expanded across South America, while Western retreats reframed it as a ritual for healing and insight.
• Home chemistry and online networks — Online forums like The DMT Nexus (founded mid-2000s) and later social media platforms made extraction guides, experience reports, and harm-reduction knowledge accessible to a wide audience. This grassroots infrastructure turned DMT into a collective open-source phenomenon, blurring the line between chemistry, spirituality, and citizen science.
• Media and popularization — Journalists and filmmakers such as Hamilton Morris brought DMT to mainstream audiences, portraying it with both curiosity and rigor, while online podcasts and YouTube documentaries made it a recurring cultural topic.
• Until now — By the early 2020s, DMT had reached a stable dual identity: a scientifically intriguing yet philosophically elusive molecule. Its mechanisms are increasingly understood, but its meaning—personal, cultural, and existential—remains unresolved.